Pulse Biosciences Inc (6L8)
XSTU
Real-time Data
06:00 AM
Day's Range
43.4052 wk Range
10.80Overview - 6L8 - Pulse Biosciences Inc
Key Statistics
Valuation
Enterprise Value
-73.20M
P/E (Trailing)
‪-40.37‬
PEG Ratio
‪-1.41‬
Price / Book
‪30.32‬
EV / EBITDA
‪0.96‬
Profitability
Gross Margin
‪37.09%‬
Profit Margin
‪-54.00%‬
Operating Margin
‪-21,982.57%‬
Return on Assets
‪-76.98%‬
Return on Equity
‪-90.23%‬
Ownership
Shares Outstanding
70.79M
Price stats
50-Day Avg
‪39.73‬
200-Day Avg
‪23.63‬
Peers - 6L8 - Pulse Biosciences Inc
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XSTU.
- 6L8XSTUPulse Biosciences, Inc.+62.84%52-week change-40.37P/E (Trailing)‪-54.00%‬Profit Margin
- PDXNXSTUPro-Dex, Inc.+42.52%52-week change—P/E (Trailing)—Profit Margin
- 1MDXSTUModern Dental Group Ltd.+33.72%52-week change1.35P/E (Trailing)‪55.79%‬Profit Margin
- 5FRXSTUMenicon Co., Ltd.+33.68%52-week change0.15P/E (Trailing)‪53.81%‬Profit Margin
- UG2XSTUAngioDynamics Inc.+33.33%52-week change-15.11P/E (Trailing)‪54.62%‬Profit Margin
- RGNXSTURepligen Corporation+33.02%52-week change163.74P/E (Trailing)‪52.31%‬Profit Margin
- BJX1XSTUBioLife Solutions Inc.+32.53%52-week change-368.89P/E (Trailing)‪64.56%‬Profit Margin
Profile Summary - 6L8 - Pulse Biosciences Inc
About
Pulse Biosciences, Inc. is a bioelectric medicine company specializing in the development of novel Nanosecond Pulsed Field Ablation (nsPFA) platforms. Its primary focus centers on the patented nPulse technology, which enables precise, non-thermal ablation of soft tissues for applications in dermatology, cardiology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
